Seguir
Professor Bhupinder Singh Bhoop
Professor Bhupinder Singh Bhoop
Emeritus Prof, Chitkara Univ, Pb, India; Ex- Prof, HoD & Dean, UIPS, Pb. Univ, Chd, India
Dirección de correo verificada de chitkara.edu.in
Título
Citado por
Citado por
Año
Pharmaceutical experimental design
GA Lewis, D Mathieu, R Phan-Tan-Luu
CRC press, 1998
9971998
Oral lipid-based formulations
DJ Hauss
Advanced drug delivery reviews 59 (7), 667-676, 2007
7482007
Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers
N Ahuja, OP Katare, B Singh
European Journal of Pharmaceutics and Biopharmaceutics 65 (1), 26-38, 2007
5372007
Optimizing drug delivery systems using systematic" design of experiments." Part I: fundamental aspects
B Singh, R Kumar, N Ahuja
Critical Reviews™ in Therapeutic Drug Carrier Systems 22 (1), 2005
4842005
Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications
B Singh, S Bandopadhyay, R Kapil, R Singh, OP Katare
Critical Reviews™ in Therapeutic Drug Carrier Systems 26 (5), 2009
3932009
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
S Dhawan, R Kapil, B Singh
Journal of Pharmacy and Pharmacology 63 (3), 342-351, 2011
2792011
Formulation and Optimization of Controlled Release Mucoadhesive Tablets of Atenolol Using Response Surface Methodology
B Singh, SK Chakkal, N Ahuja
AAPS PharmSciTech 7 (1), 206-213, 2006
2642006
Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity
K Raza, B Singh, S Lohan, G Sharma, PY Yachha, OP Katare
International Journal of Pharmaceutics 456 (1), 65-72, 2013
2322013
Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides
S Bandyopadhyay, OP Katare, B Singh
Colloids and Surfaces B: Biointerfaces 100, 50-61, 2012
2092012
Optimizing drug delivery systems using systematic" design of experiments." Part II: retrospect and prospects
B Singh, M Dahiya, V Saharan, N Ahuja
Critical Reviews™ in Therapeutic Drug Carrier Systems 22 (3), 2005
2062005
Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects
B Singh, R Kapil, M Nandi, N Ahuja
Expert Opinion on Drug Delivery 8 (10), 1341-1360, 2011
1802011
Development of Controlled Release Bucco-Adhesive Hydrophilic Matrices of Diltiazem Hydrochloride: Optimization of Bioadhesion, Dissolution and Diffusion Parameters
B Singh, N Ahuja
Drug Development and Industrial Pharmacy 28 (4), 431-42, 2002
1792002
Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment
V Garg, H Singh, A Bhatia, K Raza, SK Singh, B Singh, S Beg
AAPS PharmSciTech 18 (1), 58-71, 2017
1712017
Quantitative structure–property relationships in pharmaceutical research–Part 1
M Grover, B Singh, M Bakshi, S Singh
Pharmaceutical science & technology today 3 (1), 28-35, 2000
1642000
Optimized Nanoemulsifying Systems with Enhanced Bioavailability of Carvedilol
B Singh, R Singh, S Bandyopadhyay, R Kapil, B Garg
Colloids and Surfaces B: Biointerfaces 101, 465-474, 2013
1622013
Development of Solid Self-Nanoemulsifying Granules (SSNEGs) of Ondansetron Hydrochloride with Enhanced Bioavailability Potential
S Beg, SS Jena, CN Patra, M Rizwan, S Swain, J Sruti, ME Rao, B Singh
Colloids and Surfaces B: Biointerfaces 101, 414–423, 2013
1562013
Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors
OP Katare, K Raza, B Singh, S Dogra
Indian Journal of Dermatology, Venereology, and Leprology 76 (6), 612-621, 2010
1562010
Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer
A Jain, A Jain, NK Garg, RK Tyagi, B Singh, OP Katare, TJ Webster, ...
Acta biomaterialia 24, 140-151, 2015
1532015
Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne
K Raza, B Singh, P Singal, S Wadhwa, OP Katare
Colloids and Surfaces B: Biointerfaces 105, 67-74, 2013
1502013
Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity
A Jain, G Sharma, G Ghoshal, P Kesharwani, B Singh, US Shivhare, ...
International Journal of Pharmaceutics 546 (1-2), 97-105, 2018
1462018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20